ATE155039T1 - Mit zucker überzogene pharmazeutische dosierungseinheit - Google Patents

Mit zucker überzogene pharmazeutische dosierungseinheit

Info

Publication number
ATE155039T1
ATE155039T1 AT94203732T AT94203732T ATE155039T1 AT E155039 T1 ATE155039 T1 AT E155039T1 AT 94203732 T AT94203732 T AT 94203732T AT 94203732 T AT94203732 T AT 94203732T AT E155039 T1 ATE155039 T1 AT E155039T1
Authority
AT
Austria
Prior art keywords
dosage unit
pharmaceutical dosage
sugar coated
coated pharmaceutical
sugar
Prior art date
Application number
AT94203732T
Other languages
English (en)
Inventor
Haan Pieter De
Marcus Johannes Maria Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE155039T1 publication Critical patent/ATE155039T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94203732T 1993-12-23 1994-12-22 Mit zucker überzogene pharmazeutische dosierungseinheit ATE155039T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93203645 1993-12-23

Publications (1)

Publication Number Publication Date
ATE155039T1 true ATE155039T1 (de) 1997-07-15

Family

ID=8214236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94203732T ATE155039T1 (de) 1993-12-23 1994-12-22 Mit zucker überzogene pharmazeutische dosierungseinheit

Country Status (16)

Country Link
US (1) US5662936A (de)
EP (1) EP0659432B1 (de)
JP (1) JPH07206681A (de)
KR (1) KR100330560B1 (de)
CN (1) CN1108929A (de)
AT (1) ATE155039T1 (de)
AU (1) AU685538B2 (de)
CA (1) CA2138451C (de)
DE (2) DE659432T1 (de)
DK (1) DK0659432T3 (de)
ES (1) ES2105501T3 (de)
FI (1) FI116035B (de)
GR (1) GR3024817T3 (de)
NO (1) NO305273B1 (de)
NZ (1) NZ270228A (de)
ZA (1) ZA949929B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
CA2205897A1 (en) * 1994-11-22 1996-05-30 Malcolm Cecil Pike Compositions and methods for contraception and for treatment of benign gynecological disorders
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
PT927556E (pt) * 1997-09-23 2000-12-29 Akzo Nobel Nv Unidades de dosagem de esteroides com um revestimento para selagem destes
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
DE60008425T2 (de) * 1999-10-11 2004-12-02 Innovata Biomed Ltd., St. Albans Medikamentenabgabevorrichtung mit einer feuchtigkeitsbeständigen beschichtung
US6254888B1 (en) 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
CA2403594A1 (en) * 2000-03-27 2002-09-18 Kyowa Hakko Kogyo Co., Ltd. Granules having good taking property
DE60116758T2 (de) * 2000-05-18 2006-11-02 Therics, Inc. Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform
JP2002068965A (ja) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd 単層糖衣錠及びその製造方法
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
BRPI0509348A (pt) 2004-04-21 2007-09-11 Innovata Biomed Ltd inalador
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
DE602005023193D1 (de) * 2004-10-15 2010-10-07 Suedzucker Ag Verbessertes trommelcoating-verfahren
JP4808453B2 (ja) * 2005-08-26 2011-11-02 株式会社荏原製作所 研磨方法及び研磨装置
JP2009509974A (ja) * 2005-09-23 2009-03-12 スレッシュオールド ファーマシューティカルズ， インコーポレイテッド 抗癌治療
CN103281913A (zh) * 2010-12-29 2013-09-04 雀巢产品技术援助有限公司 包含团聚的油粉的糖果产品
CN104582492B (zh) * 2012-07-03 2018-06-12 雀巢产品技术援助有限公司 包含团聚油粉末的甜食产品
CN105121536A (zh) * 2012-11-22 2015-12-02 赢创罗姆有限公司 由粉末组合物制备颗粒状产品的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
AU685538B2 (en) 1998-01-22
EP0659432A1 (de) 1995-06-28
DE69404116D1 (de) 1997-08-14
EP0659432B1 (de) 1997-07-09
US5662936A (en) 1997-09-02
FI946043A (fi) 1995-06-24
KR100330560B1 (ko) 2002-09-05
DE69404116T2 (de) 1997-11-13
CA2138451A1 (en) 1995-06-24
NO305273B1 (no) 1999-05-03
FI116035B (fi) 2005-09-15
CN1108929A (zh) 1995-09-27
ES2105501T3 (es) 1997-10-16
KR950016715A (ko) 1995-07-20
GR3024817T3 (en) 1998-01-30
DK0659432T3 (da) 1998-02-16
FI946043A0 (fi) 1994-12-22
NO944991D0 (no) 1994-12-22
DE659432T1 (de) 1997-01-30
ZA949929B (en) 1995-08-23
JPH07206681A (ja) 1995-08-08
CA2138451C (en) 2007-04-24
NZ270228A (en) 1995-09-26
AU8168494A (en) 1995-06-29
NO944991L (no) 1995-06-26

Similar Documents

Publication Publication Date Title
ATE155039T1 (de) Mit zucker überzogene pharmazeutische dosierungseinheit
DK0402950T3 (da) Behandling af postmenopausale ulemper
IL103516A0 (en) Cytotoxic bicyclo(7,3,1)tridec-4-ene-2,6-diyne compounds,process for the preparation thereof and pharmaceutical compositions containing them
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
NO940777L (no) Anvendelse av et pregnanderivat
HUP9900924A3 (en) Substituted 1 betha-d-arabinofuranosylcytosine derivatives and use of the same for producing pharmaceutical compositions having antitumor activity
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
MX9204815A (es) Hexahidrobenzo[f]quinolinonas y formulacion farmaceutica que las comprende.
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
AU8186291A (en) A controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
DK115789D0 (da) Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
ITMI911122A0 (it) Composizioni per la terapia topica delle ustioni
ES2184285T3 (es) Compuestos farmaceuticos que contienen diclorhidrato de cinconina.
SE9303289D0 (sv) The use of inositoltrisphosphate for the preparing of medicaments
MX9601659A (es) Antagonistas del receptor de adhesion, procedimiento para prepararlos, composiciones farmaceuticas que los contienen y su empleo para preparar medicamentos y combatir enfermedades.
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee